Heqettherapeutics
1 known investors
Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction. Its compounds target multiple pathways through the upregulation of certain non-coding RNAs to promote heart regeneration.
Founders & leadership
MG
Mauro GiaccaFounder (Professor of Cardiovascular Sciences)
Investors · 1
Frequently asked questions
- What does Heqettherapeutics do?
- Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction. Its compounds target multiple pathways through the upregulation of certain non-coding RNAs to promote heart regeneration.
- Who founded Heqettherapeutics?
- Heqettherapeutics was founded by Mauro Giacca.
- Who are Heqettherapeutics's investors?
- Heqettherapeutics's investors include Claris Ventures.